RPT-J&J seeks over $5 bln in damages from Boston Scientific at trial

NEW YORK, Nov 19 (Reuters) - Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp , Johnson & Johnson finally has a chance for payback at a multibillion-dollar trial set to begin on Thursday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.